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Congenital stationary night blindness (CSNB) is a nonprogressive retinal disorder that can be associated with impaired night vision.
The last decade has witnessed huge progress in ophthalmic genetics, including the identification of three genes implicated in the
pathogenicity of autosomal-recessive CSNB. However, not all patients studied could be associated with mutations in these genes and
thus other genes certainly underlie this disorder. Here, we report a large multigeneration family with five affected individuals manifest-
ing symptoms of night blindness. A genome-wide scan localized the disease interval to chromosome 15q, and recombination events in
affected individuals refined the critical interval to a 10.41 cM (6.53 Mb) region that harbors SLC24A1, a member of the solute carrier
protein superfamily. Sequencing of all the coding exons identified a 2 bp deletion in exon 2: c.1613_1614del, which is predicted to
result in a frame shift that leads to premature termination of SLC24A1 (p.F538CfsX23) and segregates with the disorder under an auto-
somal-recessive model. Expression analysis using mouse ocular tissues shows that Slc24a1 is expressed in the retina around postnatal
day 7. In situ and immunohistological studies localized both SLC24A1 and Slc24a1 to the inner segment, outer and inner nuclear layers,
and ganglion cells of the retina, respectively. Our data expand the genetic basis of CSNB and highlight the indispensible function of
SLC24A1 in retinal function and/or maintenance in humans.Hereditary retinal diseases represent a broad range of
retinal dysfunction and/or degeneration, including
congenital stationary night blindness (CSNB). CSNB is a
clinically and genetically heterogeneous group of nonpro-
gressive retinal disorders that can be characterized by
impaired night vision, decreased visual acuity, nystagmus,
myopia, and strabismus.1 On the basis of the electroretino-
graphic recordings that exhibit waveforms in response to
flashes of light, which correspond to changes in the polar-
ization of the photoreceptor and bipolar cells, CSNB can be
classified in two groups.2,3 The Schubert-Bornschein type
is characterized by an electronegative electroretinogram
(ERG) at the scotopic bright flash, in which the amplitude
of the b-wave is smaller than that of the a-wave,2 whereas
the Riggs type is defined by proportionally reduced a- and
b-waves.3 The Schubert-Bornschein and Riggs types of
CSNB patients not only differ electrophysiologically, but
manifest different clinical characteristics. Decreased visual
acuity, myopia, and nystagmus can be associated with
Schubert-Bornschein CSNB. To date, only a few cases of
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no symptoms of myopia and/or nystagmus.1
Familial cases of CSNB with autosomal-dominant,
autosomal-recessive, or X-linked inheritance have been
reported. Mutations in RHO (MIM 180380), PDE6B (MIM
180072), and GNAT1 (MIM 139330) have been associated
with autosomal-dominant CSNB, and patients with muta-
tions in these genes show the Riggs or Schubert-Born-
schein type of ERG.4–9 On the other hand, all reported
autosomal-recessive and X–linked cases manifest a typical
Schubert-Bornschein form of ERG, which can be further
subdivided into complete and incomplete forms. Clini-
cally complete CSNB is characterized by a drastically
reduced rod b-wave response but largely normal 30 Hz
flicker cone responses due to solely ON bipolar cell
dysfunction, whereas the incomplete type is characterized
by both a reduced rod b-wave and substantially reduced
30 Hz flicker cone responses, due to both ON and OFF
bipolar cell dysfunction.10 Mutations in GRM6 (MIM
604096) and TRPM1 (MIM 603576) lead to autosomal-
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Figure 1. Pedigree of Family PKRP070 with Alleles for Chromosome 15q Markers
Alleles forming the risk haplotypes are shaded black, alleles cosegregating with the risk haplotype without homozygosity are shaded
gray, and alleles not cosegregating with CSNB are shown in white.(MIM 300278) to X-linked complete CSNB.11–17 Mutations
in CABP4 (MIM 608965) have been associated with auto-
somal-recessive incomplete CSNB, and mutations in CAC-
NA1F (MIM 300110) with X-linked incomplete CSNB.18–20
Herein, we report a large consanguineous pedigree
named PKRP070 consisting of five affected individuals in
four sibships (Figure 1). The family was recruited to partic-
ipate in a collaborative study between the National Centre
of Excellence in Molecular Biology (NCEMB, Pakistan)
and the National Eye Institute (NEI, USA) to identify
genetic lesions associated with retinal dystrophies. Institu-
tional review board approval was obtained from both
institutes, and the participating subjects gave informed
written consent consistent with the tenets of the Declara-
tion of Helsinki. Family PKRP070 resides in the southern
part of the Punjab province of Pakistan, and altogether
25 individuals from this family agreed to participate in
this study. A detailed medical history was obtained by in-
terviewing of family members; patients were queried
regarding age at onset, progression, and any other ocular
or systemic abnormalities or diseases. All affected individ-
uals complained about night blindness with normal day
vision since early childhood. Four of the five affected indi-
viduals underwent a detailed ocular examination, and the
clinical characteristics of these affected individuals are
detailed in Table 1.
Ophthalmological examinations consisting of indirect
dilated funduscopy were performed at Layton Rahmatulla
Benevolent Trust (LRBT) hospital, Lahore, Pakistan.
Fundus photographs were acquired with a Nikon camera
(model D70S). Fundus examination revealed no obvious
anomalies; the retinal vasculature, optic disc, and maculae524 The American Journal of Human Genetics 87, 523–531, Octoberwere normal (Figure 2). Additionally, no intraretinal
pigment migration was visible in the peripheral or central
region of the retina (Figure 2). ERG measurements were
recorded with equipment manufactured by LKC (Gaithers-
burg, MD, USA). Full-field ERG was performed on four
affected individuals and one normal individual of family
PKRP070. For scotopic ERG, patients were dark adapted
and rod response was determined through incident
flash attenuated by 25 dB, while the rod-cone response
was measured at 0 dB. Cone response was recorded at
0 dB with 30 Hz flicker and background illumination of
20 cd/m2. ERG recordings demonstrated the absence of
both a- and b-waves under the scotopic condition. Under
the photopic condition, cone response was modestly
reduced in individuals 14 and 18, whereas for individuals
28 and 34, the response was undistinguishable from the
unaffected control (Figure S1, available online). Addition-
ally, the rod response at 25 dB was absent in all four
affected individuals and was not recovered 4 hr after dark
adaptation (Figure S2). Taken together, the fundus photo-
graphs and the ERG results of rod response are strongly
suggestive of CSNB with a Riggs type of ERG.
Blood samples were collected from all participating
members—both affected individuals and unaffected
individuals—and genomic DNA was extracted as de-
scribed.21,22 The size of the pedigree suggested sufficient
power to achieve genome-wide statistical significance
under a fully penetrant autosomal-recessive model. We
therefore completed a genome-wide scan with 382 poly-
morphic fluorescent markers with an average resolution
of 10 cM, from the ABI PRISM Linkage Mapping Set
MD-10 (Applied Biosystems, Foster City, CA, USA).8, 2010
Table 1. Clinical Characteristics of Affected Individuals of Family PKRP070 Diagnosed with Autosomal-Recessive CSNB
Visual Acuity
Individual ID First Symptoms OD OS
Disease
Progression Fundus Findings
Electroretinographic
Characteristics
14 night blindness since
early childhood
6/6 6/6 stationary no macular atrophy,
no pigment deposition,
and no vascular attenuation
a- and b-waves are absent under the
scotopic condition, whereas the cone
responses are somewhat reduced
under the photopic condition
18 night blindness since
early childhood
6/6 6/24 stationary no macular atrophy,
no pigment deposition,
and no vascular attenuation
a- and b-waves are absent under the
scotopic condition, whereas the cone
responses are somewhat reduced
under the photopic condition
28 night blindness since
early childhood
6/18 6/9 stationary no macular atrophy,
no pigment deposition,
and no vascular attenuation
a- and b-waves are absent under the
scotopic condition with normal cone
responses under the photopic
condition
34 night blindness since
early childhood
6/6 6/6 stationary no macular atrophy,
no pigment deposition,
and no vascular attenuation
a- and b-waves are absent under the
scotopic condition with normal cone
responses under the photopic
condition
OD, oculus dexter (right eye); OS, oculus sinister (left eye).Multiplex PCRs were carried with the GeneAmp PCR
System 9700 (Applied Biosystems), resolved on an
ABI3100 DNA analyzer, and analyzed with GeneMapper
(Applied Biosystems). Two-point linkage analyses were per-
formed with the FASTLINK version of MLINK from the
LINKAGE program package, whereas maximum two-point
LOD scores were calculated with ILINK.23,24 Autosomal-
recessive CSNB was analyzed as a fully penetrant trait
with a disease allele frequency of 0.001. The marker order
and distances between the markers were obtained from
the Marshfield Clinic database (see Web Resources) and
the National Center for Biotechnology Information chro-
mosome 15 sequence maps. Equal allele frequencies were
assumed for the initial genome scan, whereas for fine
mapping, allele frequencies were derived from 96 unre-
lated and unaffected individuals. During the genome-
wide scan, a two-point LOD score of 4.81 at q ¼ 0 was
obtained with marker D15S153 (Table 2). No significant
LOD scores (LOD > 3.0) were obtained with markers other
than D15S153 during the genome-wide scan (Figure S3).
Additional STR markers proximal and distal to D15S153
were selected from theMarshfield database and genotyped.
As shown in Table 2, LOD scores of 5.92, 2.55, 5.55, 2.95,
and 4.91 at q ¼ 0 were obtained with D15S993,
D15S1507, D15S1020, D15S213, and D15S988, respec-
tively (Table 2). A recombination event in individual 25
at D15S974 defines the proximal boundary, and the distal
breakpoint was obtained from individual 14 at D15S127,
delimiting the critical linkage interval to a 27.76 cM
(28.52 Mb) region on chromosome 15q22.2-q26.1 (Fig-
ure 1). Lack of homozygosity in affected individual 18 at
D15S1025 further delimits the critical region to a
10.41cM (6.53Mb) interval flanked by markers D15S974
proximally and D15S1025 distally.
The critical interval on chromosome 15q is a gene-rich
region that harbors 109 annotated genes according to theThe AmericUCSC database. We therefore prioritized candidate genes
on the basis of their known function and available expres-
sion data in the retina and systematically started se-
quencing them by using the DNA samples from one
affected and one unaffected individual of family
PKRP070. SLC24A1 (MIM 603617), a sodium-calcium
exchanger, was considered a plausible candidate because
of its functionality and expression in the rod outer
segment.25–27 The SLC24A1 transcript spans 5.7 kb and
consists of ten exons that encode a 1099 amino acid pro-
tein. Previously, Sharon and colleagues investigated the
involvement of SLC24A1and SLC24A2 (MIM 609838) in
retinal diseases and identified 27 previously unreported
sequence changes in SLC24A1.28 Of these, 21 variations
were not considered sufficient to cause disease because
they either did not cosegregate with the disease phenotype
or did not affect conserved amino acid residues.28 The re-
maining two frameshift, three missense, and one likely
previously unreported splice-site change were heterozy-
gous variations, and although they were considered plau-
sible, they could not be conclusively associated with the
retinal disease phenotype because of the absence of the
other pathogenic allele.28 Nonetheless, given the reported
expression in the rod outer segment and the presence in
the linkage interval, SLC24A1 remained an excellent
candidate, and we therefore sequenced the coding exons,
and exon-intron boundaries of SLC24A1. Primer pairs for
individual exons of SLC24A1 and amplification conditions
are available upon request. The PCR primers for each exon
were used for bidirectional sequencing with the BigDye
Terminator Ready reactionmix, according tomanufacturer
instructions. Sequencing products were precipitated and
resuspended in 10 ml of formamide (Applied Biosystems)
and denatured at 95C for 5 min. Sequencing was per-
formed in an ABI PRISM 3100 Automated Sequencer
(Applied Biosystems). Sequencing results were assembledan Journal of Human Genetics 87, 523–531, October 8, 2010 525
Figure 2. Fundus Photographs of Family PKRP070
(A) OD and OS of affected individual 14.
(B) OD and OS of affected individual 18.
(C) OD and OS of affected individual 28.
(D) OD and OS of affected individual 34.
(E) OD and OS of unaffected individual 35.
OD, oculus dexter (right eye); OS, oculus sinister (left eye).with ABI PRISM sequencing analysis software version 3.7
and analyzedwith SeqScape software (Applied Biosystems).
Sequencing of SLC24A1 (NM_004727.2) in an affected
individual identified a homozygous 2 bp deletion in
exon 2, c.1613 _1614del (Figure 3), which is predicted to526 The American Journal of Human Genetics 87, 523–531, Octoberresult in a frameshift leading to either premature termina-
tion of the encoded protein, p.F538CfsX23, or nonsense-
mediated decay. This mutation segregates with the disease
phenotype in the family: all affected individuals are
homozygous for this change, whereas unaffected individ-
uals are either heterozygous carriers or homozygous for
the wild-type allele. Moreover, we did not find this change
in 384 control chromosomes from the Punjab province of
Pakistan or in 192 chromosomes of northern European
descent. The clinical data of the patient presented herein
are suggestive of CSNB with a Riggs type of ERG, and to
date this form of CSNB has been described in only few
cases with autosomal-dominant CSNB. Although our
cohort does not contain any additional CSNB patients or
families with a specific Riggs type of ERG, given the fact
thatmany genes associated with retinal dystrophies harbor
a wide spectrum of mutations responsible for different
retinal phenotypes, we screened 16 different CSNB
patients with the following inclusion criteria: patients
with an incomplete or complete phenotype were females,
and/or their phenotype was excluded in all CSNB-associ-
ated genes described to date, and/or consanguinity was
noted and thus was indicative of autosomal-recessive
inheritance, or their phenotype was not further classified
into complete or incomplete CSNB. Additionally, we
screened 48 probands from our familial cohort of auto-
somal-recessive RP. However, no additional pathogenic
mutations were identified in SLC24A1.
We then examined the expression of Slc24a1 in post-
natal eyes (postnatal day 1 [P01] to P30) of C57BL/6
mice. Quantitative RT-PCR (qRT-PCR) was performed on
different mouse eye tissues, with forward primer 50-GGG
AAAGAACACTGCGGTAA-30 and reverse primer 50-CCCAT
CCTGGTGCTTACTGT-30, and the data were analyzed as
published.29 The expression of Slc24a1 was normalized
against two housekeeping genes, Gapdh (MIM 138400)
and RpL19 (MIM 180466), as described previously.30
Expression levels (mean 5 SEM) were calculated by
analyzing at least three independent samples with replica
reactions andpresentedonanarbitrary scale that represents
the expression over the housekeeping genes. Rhodopsin
mRNA levels served as a molecular marker for photore-
ceptor development and were measured in the same set of
samples. We observed minimal expression of either
Slc24a1 or rhodopsin prior to P05; however, the expression
of both genes increased fromP07, suggesting that Slc24a1 is
present in photoreceptors (Figure 4A). The level of
rhodopsin in the retina shows a steady increase after P7,
reaching a maximum level at P30 (Figure 4A).31 Although,
not surprisingly, the level of expression of the Slc24a1 tran-
script is much lower than that of rhodopsin, the profile is
similar, with a steady increase from P07 to P30 (Figure 4A).
Once the expression of Slc24a1 in the mouse eye was
confirmed, we investigated the expression of Slc24a1 in
various eye tissues of 24-week-old C57BL/6 mice. Slc24a1
transcript was detected in the retina, followed by low levels
of expression in the iris-cilliary body and retinal pigment8, 2010
Table 2. Two-Point LOD Scores of Chromosome 15q Markers for Family PKRP070
Marker cM Mb 0 0.01 0.05 0.09 0.1 0.2 0.3 Zmax qmax
D15S1036 57.37 62.55 N 1.10 1.54 1.52 1.49 1.07 1.10 1.54 0.05
D15S974 59.05 62.87 N 2.71 2.99 2.81 2.75 1.97 2.71 2.99 0.05
D15S993 59.61 64.21 5.92 5.78 5.22 4.65 4.51 3.08 1.73 5.62 0.00
D15S1507 60.17 65.34 2.55 2.5 2.26 2.01 1.95 1.3 0.71 2.55 0.00
D15S1020 61.28 65.99 5.55 5.42 4.88 4.33 4.21 2.88 1.60 5.55 0.00
D15S213 62.40 66.45 2.95 2.86 2.49 2.13 2.04 1.15 0.43 2.95 0.00
D15S153a 62.40 66.55 4.81 4.68 4.18 3.68 3.56 2.35 1.26 5.91 0.00
D15S988 66.90 67.32 4.91 4.79 4.33 3.86 3.74 2.55 1.42 4.91 0.00
D15S1025 69.46 69.40 0.64 0.08 0.39 0.49 0.5 0.44 0.08 0.50 0.10
D15S127a 86.81 91.39 N 4.48 1.41 0.48 0.34 0.29 0.30 0.30 0.30
LOD scores were calculated at different q values for each marker.
a Marker included in genome scan.epithelium (Figure 4B). Slc24a1 is either not expressed or
expressed at low levels in themouse cornea, lens, and optic
nerve (Figure 4B). The levels of Slc24a1 expressed in the
mouse retina prompted us to further investigate the tran-
script levels in different retinal layers. We generated RNA
probes (size ranging from 200 bp to 1200 bp) fromThe America cDNA clone of SLC24A1 and performed in situ hybridiza-
tion on 7 mm cryosections from the posterior segment of
the human eye according to published protocols.32 In
situ hybridization detected SLC24A1 message in the inner
segment, the outer and inner nuclear layers, and ganglion
cells (Figure 5).Figure 3. Sequence Chromatogram
Illustrating the Causal Lesions and the
Topological Model of SLC24A1
(A–C) Individual 11 (A), individual 12 (B),
and individual 14 (C) show the wild-type
allele, heterozygous, and homozygous
2 bp deletion c.1613_1614del, respectively.
The underlined are the two bases deleted
in the affected individuals of family
PKFP070.
(D) Transmembrane domains of SLC24A1
predicted by Simple Modular Architecture
Research Tools (SMART) algorithms. The
deletion mutation resides in the fourth
transmembrane that constitutes the first
of two proposed ion exchanger domains
of SLC24A1.
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Figure 4. Quantitative Expression Analyses in the Adult Mouse
Eye Tissue
(A) Expression of Slc24a1 and Rhodopsin was determined by qRT-
PCR in the mouse eyes at P01, P03, P05, P10, P15, and P30.
Slc24a1 expression is presented as bars on an arbitrary scale, and
Rhodopsin expression is presented as a line. All values are the
mean (5 SEM) of three independent observations after normaliza-
tion with the control gene (Rpl-19) expression.
(B) Quantitative expression of Slc24a1 in adult mouse eye tissue
(180 days). Slc24a1 expression is presented as bars using an arbi-
trary scale on the y axis. Values are presented as the mean (5
SEM) of three independent observations after normalization
with the control gene (Rpl-19) expression. RPE, retinal pigment
epithelium; ON, optic nerve.
Figure 5. Localization of SLC24A1 in Human Retina with In Situ
Hybridization Using Digoxigenin-Labeled Sense and Antisense
Probes
Hybridization with sense probe as a control (left) and antisense
probe (right) show strong labeling (black arrows) in the inner
segment, outer and inner nuclear layers, and ganglion cell layer.
OS, outer segment; IS, inner segment; ONL, outer nuclear layer;
OPL, outer plexiform layer; IPL, inner plexiform layer; GCL,
ganglion cell layer.Previously, Reid and colleagues identified a sodium-
calcium exchanger protein in the bovine rod outer seg-
ments and localized it exclusively to the plasmamembrane
of rod outer segments.25 Because our in situ results sug-
gested a broader localization pattern for SLC24A1, we
sought additional evidence and used a commercially avail-
able anti-SLC24A1 antibody (SAB2102180, Sigma-Aldrich,
St. Louis, MO, USA) to detect Slc24a1 in different mouse
retinal layers. P13 and adult CD1 mouse eyes were
dissected and fixed overnight in 4% paraformaldehyde
(ElectronMicroscopy Services) in 13 PBS. After cryoprotec-
tion using a sucrose gradient, mouse eyes were embedded
in optimal cutting temperature compound medium. The
retinal distribution of Slc24a1 was visualized by incubating
12-mm-thick sections of the retina with rabbit polyclonal
anti-SLC24A1 antibody at 1:250 dilution overnight at528 The American Journal of Human Genetics 87, 523–531, October4C, followed by goat anti-rabbit IgG conjugated with
AlexaFluor 594 (Invitrogen). Slides were costained for F-
actin with AlexaFluor488-conjugated phalloidin
(Invitrogen, A12379) and nuclei with the use of Hoechst
33342 (1:2000 dilutions of each). Apotome-sectioned
images were captured with a Zeiss Imager Z1 microscope
equipped with AxioVS40 software version 4.8.1.0.
Slc24a1 was detected in the inner segment, the outer and
inner nuclear layers, and ganglion cells in both the P13
and adult mouse eyes, consistent with the results of the
in situ hybridization experiment (Figure 6).
The genomic structure of this locus predicts that
the pathogenic frameshift mutation will likely trigger
nonsense-mediated decay (NMD). Even if some of the
mutant mRNA escapes NMD, the topological models pre-
dicted by SMART algorithms suggest that the mutation
resides early in the first of the two Naþ/Ca2þ- Kþ ion
exchanger domains and as such the resulting protein will
lack part of the first and the entire second Naþ/Ca2þ- Kþ
ion exchanger domains that are involved in binding and
transport of these physiologically important cations.
Thus, either way the mutation is expected to have delete-
rious effect on the transport activity of SLC24A1. Calcium
and sodium ions enter the rod outer segment through8, 2010
Figure 6. Immunolocalization of Slc24a1 Expression in P13 and Adult Mouse Retinal Layers
The slides were stained for Slc24a1 with goat anti-rabbit IgG conjugated with AlexaFluor 594 (red), F-actin using AlexaFluor488 conju-
gated phalloidin (green), and nuclei using Hoechst 33342 (blue). Merge represents an overlay of images from the first three columns in
P13 and adult mouse retinal layers, respectively. The localization pattern illustrates a strong signal in the inner segment, outer and inner
nuclear layers, and ganglion cell layer. The scale bar represents 50 um. OS, outer segment; IS, inner segment; ONL, outer nuclear layer;
OPL, outer plexiform layer; IPL, inner plexiform layer; GCL, ganglion cell layer.cGMP-gated channels,26 and Ca2þ balance is thought to be
maintained by SLC24A1, where extrusion of Ca2þ is
coupled with an inward flux of Naþ. The complete or even
partial loss of the ion exchange function would result in
abnormal levels of intracellular Ca2þ concentrations that
could potentially interfere with the proper functioning of
the rod photoreceptors, resulting in the disease phenotype.
In that regard, it is perhaps surprising that the homozygous
frameshift results in a CSNB, but not an RP, phenotype. It is
potentially significant that Sharon and colleagues reported
several variations in SLC24A1 in RP patients but none of
them could be causally associated with a retinal pheno-
type.28 As such, it is possible that this locus is sufficient to
cause CSNB but also contributes modifying alleles to more
severe, progressive retinal degenerations.
It is also unclear why the loss of SLC24A1 transporter
protein that is expressed in different retinal layers
manifests its phenotype only in the rod photoreceptor
cells. One possible explanation is that a secondary trans-
port mechanism for Ca2þ rescues the loss of SLC24A1
disease phenotype in other retinal layers. Development
of an animal model will potentially help us understand
the mechanism and the molecular players that help
rescue the abnormal Ca2þ concentrations in inner
segment, inner nuclear layers, and ganglion cells and will
further elucidate the physiological significance of
SLC24A1 and its role in the pathology of CSNB.
In conclusion, we report mapping of a locus for auto-
somal-recessive CSNB to 15q in a family with a RiggsThe Americtype of ERG and subsequent identification of a pathogenic
mutation in SLC24A1, segregating in an autosomal-
recessive fashion in a consanguineous multigenerational
family. Implication of SLC24A1 in the etiology of CSNB
reaffirms the genetic heterogeneity of the disease. Further
functional analysis will aid in clarifying the intricate
details of retinal cellular machinery and rod outer segment
physiology.Supplemental Data
Supplemental Data include three figures and can be found with
this article online at http://www.cell.com/AJHG/.Acknowledgments
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